291 related articles for article (PubMed ID: 17626889)
1. High-fat diet induced neuropathy of pre-diabetes and obesity: effects of "healthy" diet and aldose reductase inhibition.
Obrosova IG; Ilnytska O; Lyzogubov VV; Pavlov IA; Mashtalir N; Nadler JL; Drel VR
Diabetes; 2007 Oct; 56(10):2598-608. PubMed ID: 17626889
[TBL] [Abstract][Full Text] [Related]
2. Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice.
Vareniuk I; Pavlov IA; Drel VR; Lyzogubov VV; Ilnytska O; Bell SR; Tibrewala J; Groves JT; Obrosova IG
Exp Neurol; 2007 Jun; 205(2):425-36. PubMed ID: 17475250
[TBL] [Abstract][Full Text] [Related]
3. The leptin-deficient (ob/ob) mouse: a new animal model of peripheral neuropathy of type 2 diabetes and obesity.
Drel VR; Mashtalir N; Ilnytska O; Shin J; Li F; Lyzogubov VV; Obrosova IG
Diabetes; 2006 Dec; 55(12):3335-43. PubMed ID: 17130477
[TBL] [Abstract][Full Text] [Related]
4. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.
Obrosova IG; Pacher P; Szabó C; Zsengeller Z; Hirooka H; Stevens MJ; Yorek MA
Diabetes; 2005 Jan; 54(1):234-42. PubMed ID: 15616034
[TBL] [Abstract][Full Text] [Related]
5. Endoplasmic reticulum stress contributes to prediabetic peripheral neuropathy.
Lupachyk S; Watcho P; Obrosov AA; Stavniichuk R; Obrosova IG
Exp Neurol; 2013 Sep; 247():342-8. PubMed ID: 23142188
[TBL] [Abstract][Full Text] [Related]
6. Inducible nitric oxide synthase gene deficiency counteracts multiple manifestations of peripheral neuropathy in a streptozotocin-induced mouse model of diabetes.
Vareniuk I; Pavlov IA; Obrosova IG
Diabetologia; 2008 Nov; 51(11):2126-33. PubMed ID: 18802679
[TBL] [Abstract][Full Text] [Related]
7. High-fat diet-induced neuropathy of prediabetes and obesity: effect of PMI-5011, an ethanolic extract of Artemisia dracunculus L.
Watcho P; Stavniichuk R; Ribnicky DM; Raskin I; Obrosova IG
Mediators Inflamm; 2010; 2010():268547. PubMed ID: 20396384
[TBL] [Abstract][Full Text] [Related]
8. A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice.
Drel VR; Pacher P; Vareniuk I; Pavlov I; Ilnytska O; Lyzogubov VV; Tibrewala J; Groves JT; Obrosova IG
Eur J Pharmacol; 2007 Aug; 569(1-2):48-58. PubMed ID: 17644085
[TBL] [Abstract][Full Text] [Related]
9. Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor.
Calcutt NA; Freshwater JD; Mizisin AP
Diabetologia; 2004 Apr; 47(4):718-24. PubMed ID: 15298349
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of Sirtuin 1 protein in neurons prevents and reverses experimental diabetic neuropathy.
Chandrasekaran K; Salimian M; Konduru SR; Choi J; Kumar P; Long A; Klimova N; Ho CY; Kristian T; Russell JW
Brain; 2019 Dec; 142(12):3737-3752. PubMed ID: 31754701
[TBL] [Abstract][Full Text] [Related]
11. Effect of the aldose reductase inhibitor fidarestat on experimental diabetic neuropathy in the rat.
Kuzumoto Y; Kusunoki S; Kato N; Kihara M; Low PA
Diabetologia; 2006 Dec; 49(12):3085-93. PubMed ID: 17063327
[TBL] [Abstract][Full Text] [Related]
12. Peripheral neuropathy in mice with neuronal nitric oxide synthase gene deficiency.
Vareniuk I; Pacher P; Pavlov IA; Drel VR; Obrosova IG
Int J Mol Med; 2009 May; 23(5):571-80. PubMed ID: 19360314
[TBL] [Abstract][Full Text] [Related]
13. Role of Fyn-mediated NMDA receptor function in prediabetic neuropathy in mice.
Suo M; Wang P; Zhang M
J Neurophysiol; 2016 Aug; 116(2):448-55. PubMed ID: 27146985
[TBL] [Abstract][Full Text] [Related]
14. Interplay of sorbitol pathway of glucose metabolism, 12/15-lipoxygenase, and mitogen-activated protein kinases in the pathogenesis of diabetic peripheral neuropathy.
Stavniichuk R; Shevalye H; Hirooka H; Nadler JL; Obrosova IG
Biochem Pharmacol; 2012 Apr; 83(7):932-40. PubMed ID: 22285226
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribose)polymerase inhibition counteracts renal hypertrophy and multiple manifestations of peripheral neuropathy in diabetic Akita mice.
Drel VR; Pacher P; Stavniichuk R; Xu W; Zhang J; Kuchmerovska TM; Slusher B; Obrosova IG
Int J Mol Med; 2011 Oct; 28(4):629-35. PubMed ID: 21617845
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the peroxynitrite decomposition catalyst Fe(III) tetra-mesitylporphyrin octasulfonate on peripheral neuropathy in a mouse model of type 1 diabetes.
Drel VR; Pacher P; Vareniuk I; Pavlov IA; Ilnytska O; Lyzogubov VV; Bell SR; Groves JT; Obrosova IG
Int J Mol Med; 2007 Dec; 20(6):783-92. PubMed ID: 17982684
[TBL] [Abstract][Full Text] [Related]
17. Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine.
Calcutt NA; Jorge MC; Yaksh TL; Chaplan SR
Pain; 1996 Dec; 68(2-3):293-9. PubMed ID: 9121817
[TBL] [Abstract][Full Text] [Related]
18. An aldose reductase inhibitor reverses early diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense.
Obrosova IG; Van Huysen C; Fathallah L; Cao XC; Greene DA; Stevens MJ
FASEB J; 2002 Jan; 16(1):123-5. PubMed ID: 11709499
[TBL] [Abstract][Full Text] [Related]
19. Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy: interactions with aldose reductase.
Price SA; Agthong S; Middlemas AB; Tomlinson DR
Diabetes; 2004 Jul; 53(7):1851-6. PubMed ID: 15220210
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of PMI-5011, an ethanolic extract of Artemisia dracunculus L., on peripheral neuropathy in streptozotocin-diabetic mice.
Watcho P; Stavniichuk R; Tane P; Shevalye H; Maksimchyk Y; Pacher P; Obrosova IG
Int J Mol Med; 2011 Mar; 27(3):299-307. PubMed ID: 21225225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
